CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Impact Award - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology studies to accelerate research into innovative immunotherapy approaches.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical research to translate promising therapeutic concepts into meaningful patient impact.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.